Iterum Therapeutics PLC (ITRM)
1.56
-0.04
(-2.50%)
USD |
NASDAQ |
May 02, 13:26
Iterum Therapeutics Cash from Financing (Quarterly): 0.589M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.589M |
| September 30, 2023 | 0.01M |
| June 30, 2023 | 0.20M |
| March 31, 2023 | 0.235M |
| December 31, 2022 | 0.433M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -2.251M |
| December 31, 2021 | -1.629M |
| September 30, 2021 | -1.634M |
| June 30, 2021 | -0.592M |
| March 31, 2021 | 86.98M |
| December 31, 2020 | 15.13M |
| September 30, 2020 | 0.767M |
| Date | Value |
|---|---|
| June 30, 2020 | 2.71M |
| March 31, 2020 | 45.87M |
| December 31, 2019 | -1.034M |
| September 30, 2019 | 3.038M |
| June 30, 2019 | 0.01M |
| March 31, 2019 | 0.049M |
| December 31, 2018 | 1.369M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 88.66M |
| March 31, 2018 | 32.18M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 45.87M |
| March 31, 2017 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.251M
Minimum
Mar 2022
86.98M
Maximum
Mar 2021
7.833M
Average
0.20M
Median
Jun 2023
Cash from Financing (Quarterly) Benchmarks
| Alkermes PLC | -276.50M |
| Endo International PLC | -149.76M |
| Jazz Pharmaceuticals PLC | -100.31M |
| Medtronic PLC | -1.50B |
| Perrigo Co PLC | -44.60M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.84M |
| Cash from Investing (Quarterly) | 13.52M |
| Free Cash Flow | -39.34M |
| Free Cash Flow Per Share (Quarterly) | -0.9742 |
| Free Cash Flow Yield | -194.6% |